The Derivative cover image

2021's Vol moves, 2022's outlook, Meme stocks, Option Flows and KAI with Cem Karsan

The Derivative

00:00

Amikron: A Big Deal for the Economy

"I think everybody's probably sick of hearing about Amikron, right? But I think Amikron's a big deal. It's not a big deal in the way people think it's a bigdeal," he says. "Now that Amakron is likely to come in, we're likely to get to herd immunity and we are likely to kind of reopen in the spring." The Fed is going to have to accelerate tapering on its quantitative easing program, according to Benzinga CEO David Kostin.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app